Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carlyle Group Inc (CG) vs ClearPoint Neuro Inc (CLPT) Price & Performance

Carlyle Group IncTrade
ClearPoint Neuro IncTrade

Price performance (Past 24H)

Key statistics

Carlyle Group Inc vs ClearPoint Neuro Inc — how do they compare? Carlyle Group Inc trades at $48.27 (market cap $17.23B), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: Carlyle Group Inc is far larger — about 37.9× ClearPoint Neuro Inc's market cap, and Carlyle Group Inc pays a 2.9% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.

CGCLPT
Market Cap
$17.23B$454.21M
Sector
FinancialsHealth
52-Week High
$69.35$29.60
52-Week Low
$40.52$8.66
Dividend Yield
2.9%
Enterprise Value
$488.79M

Returns comparison

Trailing returns across standard periods

About Carlyle Group Inc

The Carlyle Group is one of the world's largest alternative-asset managers, with $376.4 billion in total assets under management, including $259.6 billion in fee-earning AUM, at the end of June 2022. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure and natural resources funds (accounting for 41% of fee-earning AUM and 65% of base management fees during 2021), global credit (45% and 24%) and investment solutions (14% and 11%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving close to 2,700 active carry fund investors from 95 countries.

Read more on CG

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT